Novel Transcriptomic Signatures in Fibrostenotic Crohn’s Disease: Dysregulated Pathways, Promising Biomarkers, and Putative Therapeutic Targets
This study comprehensively characterizes resected CD ileal strictures, elucidating main dysregulated pathways and identifying promising biomarkers and putative therapeutic targets.
Authors
- Animesh Acharjee (ORCID: https://orcid.org/0000-0003-2735-7010)
- Uday N. Shivaji (ORCID: https://orcid.org/0000-0002-6800-584X)
- Csilla Várnai (ORCID: https://orcid.org/0000-0003-0048-9507)
- Sarah Akiror
- Asma Amamou
- Gary Reynolds (ORCID: https://orcid.org/0000-0002-3250-0582)
- Louisa Jeffery
- Giovanni Santacroce (ORCID: https://orcid.org/0000-0002-0544-0414)
- Marietta Iacucci (ORCID: https://orcid.org/0000-0002-3142-9550)
- Davide Zardo
- Georgios V. Gkoutos (ORCID: https://orcid.org/0000-0002-2061-091X)
- Subrata Ghosh (ORCID: https://orcid.org/0000-0002-1713-7797)
- Snehali Majumder
Institutions
- University Hospitals Birmingham NHS Foundation Trust (GB)
- University College Cork (IE)
- Queen Elizabeth Hospital (GB)
- Institute of Immunology (HR)
- APC Microbiome Institute (IE)
- Ospedale San Bortolo (IT)
- University of Birmingham (GB)
Publication Details
- Journal
- Inflammatory Bowel Diseases
- Published
- 2025-02-20
- DOI
- https://doi.org/10.1093/ibd/izaf021
- Citations
- 5
- Primary Topic
- Inflammatory Bowel Disease
- Type
- article
- Field-Weighted Citation Impact
- 9.09
Funders
- University Hospitals Birmingham NHS Foundation Trust